Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: Kefauver–Harris Drug Amendments | Statement: [Estes Kefauver, sponsored, Kefauver–Harris Drug Amendments]

Target entity: Kefauver–Harris Drug Amendments
Context triple: [Estes Kefauver, sponsored, Kefauver–Harris Drug Amendments]

• A. Kefauver–Harris Drug Amendments of 1962 chosen
  The Kefauver–Harris Drug Amendments of 1962 are U.S. federal regulations that strengthened drug safety and efficacy requirements, mandating proof of effectiveness and stricter oversight of pharmaceutical marketing and manufacturing.
• B. Drug Price Competition and Patent Term Restoration Act of 1984
  The Drug Price Competition and Patent Term Restoration Act of 1984, commonly known as the Hatch-Waxman Act, is a U.S. law that streamlined the approval of generic drugs while providing patent term extensions to brand-name drug manufacturers to balance innovation and competition.
• C. Prescription Drug User Fee Act of 1992
  The Prescription Drug User Fee Act of 1992 is a U.S. law that authorizes the FDA to collect fees from pharmaceutical companies to fund and expedite the review of new drug applications.
• D. Prescription Drug Marketing Act
  The Prescription Drug Marketing Act is a U.S. federal law that regulates the distribution and marketing of prescription drugs to ensure their safety, effectiveness, and integrity within the pharmaceutical supply chain.
• E. Food and Drug Administration Modernization Act of 1997
  The Food and Drug Administration Modernization Act of 1997 is a U.S. law that overhauled FDA regulatory procedures to speed the approval of drugs and medical devices while enhancing patient access to experimental therapies and modernizing agency operations.
• F. None of above.
• G. Unsure - the case is ambiguous/there is not enough information to decide.